BHVN

Biohaven
BHVN

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$2.19B
EV
$1.74B
Shares Outstanding
104.43M
Beta
4.15

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$61.00
P/E 2025E
-
P/Revenue 2025E
118.46x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Biohaven Ltd.

gainify
BHVN

Biohaven Ltd.

BHVN

Biohaven Ltd., together with its subsidiaries, focuses on discovering, developing, and commercializing therapies for immunology, neuroscience, and oncology worldwide. The company’s pipeline products include Troriluzole, which is in Phase 3 clinical trial for the treat...

Sector

Healthcare

Industry

Biotechnology

CEO

Coric, Vladimir

Employees

256

IPO Date

2022-09-23

Headquarters

215 Church Street, New Haven, Connecticut, 06510, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved